|
Background
|
Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988 [PubMed 3219362]). In addition to control of intracellular RNases, the inhibitor may have a role in the regulation of angiogenin (MIM 105850). Ribonuclease inhibitor, of 50,000 Da, binds to ribonucleases and holds them in a latent form. Since neutral and alkaline ribonucleases probably play a critical role in the turnover of RNA in eukaryotic cells, RNH may be essential for control of mRNA turnover, the interaction of eukaryotic cells with ribonuclease may be reversible in vivo.
Alias Symbols: RAI, RNH, MGC4569, MGC18200, MGC54054
Protein Interaction Partner: UBC, SDCBP, SUMO2, SUMO3, NEDD8, RAB1B, LSM2, ERO1L, PTGES3, SOX2, NPM1, gag, IQCB1, FN1, PRR12, UBQLN2, DSTN, PRDX1, COL1A1, ADSS, SIRT7, MYC, USP32P2, SLX4IP, G3BP2, TNFAIP3, RNASE1, ANG,
|
